Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04416412 · ClinicalTrials.gov registry record
ICG Fluorescence Imaging in Open Fracture Trauma Patients
A clinical trial of Trauma Injury, sponsored by Dartmouth-Hitchcock Medical Center.
- Active
- Registry status
- 180
- Enrollment target
- 4
- Study locations
NCT04416412: Active study of Trauma Injury, sponsored by Dartmouth-Hitchcock Medical Center.
NCT04416412 is a study of Trauma Injury that is active but no longer recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 180 participants, below the 489-participant average among 15 other Trauma Injury trials with a reported enrollment target (63% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04416412, a study of Trauma Injury, is active but no longer recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 180 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a prospective observational study that will evaluate the association between bone and tissue perfusion, as measured by indocyanine green (ICG) fluorescence imaging, and complications, in an effort to develop ICG fluorescence imaging as a diagnostic tool to quantitatively guide operative debridement.
Primary Outcome
All unplanned reoperations will be documented using a specific case report form
Conditions Studied
Interventions
- OTHER Immunofluorescence Imaging
Study Locations (4)
California
- University of California, Irvine - Irvine
Maryland
- University of Maryland, Baltimore R. Cowley Shock Trauma - Baltimore
Massachusetts
- Brigham and Women's Hospital - Boston
New Hampshire
- Dartmouth Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2026-01-31 |
What the registry record for NCT04416412 still lists
NCT04416412 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 489-participant average among 15 other Trauma Injury trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Trauma Injury appearing as the primary indexed condition, and to 1 intervention - of which Immunofluorescence Imaging is the first listed.
NCT04416412 reports a single indexed study location in California, Maryland, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04416412 about?
NCT04416412 is a clinical study titled "ICG Fluorescence Imaging in Open Fracture Trauma Patients". This is a prospective observational study that will evaluate the association between bone and tissue perfusion, as measured by indocyanine green (ICG) fluorescence imaging, and complications, in an effort to develop ICG fluorescence imaging as a diagnostic tool to quantitatively guide operative debr...
What is the current status of trial NCT04416412?
This trial is currently active not recruiting. The enrollment target is 180 participants. The study started on 2020-10-01. Estimated completion is 2026-01-31.
What conditions does trial NCT04416412 study?
This clinical trial studies the following conditions: Trauma Injury.
What interventions are being tested in trial NCT04416412?
The interventions under investigation include: Immunofluorescence Imaging (OTHER).
Who is sponsoring clinical trial NCT04416412?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04416412 being conducted?
This trial has 4 study locations across California, Maryland, Massachusetts, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04416412's enrollment target sits among peer trials
180 9th of 15 higher than 7 of 15 other Trauma Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trauma Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pathological Myeloid Activation After Sepsis and Trauma
RECRUITING
-
Therapy Dog Visits for Patients Hospitalized With Traumatic Injuries
RECRUITING · NA
-
Antibiotic Use in Facial Fracture Post Injury
RECRUITING
-
Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury
RECRUITING · NA
-
The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
RECRUITING
-
Bioimpedance for Ortho Trauma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI